Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive15

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive6

Views

Views
May 20245
June 20240
July 20240
August 20240
September 20240
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
United Kingdom1
 

Top cities views

Views
Chicago1
Fort Worth1